KALA BIO, Inc. has 15 Schedule 13D or 13G filings on record since 2025-09-11. 2 holders' latest filing reports 5% or more of common stock, $0.001 par value. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Oxford Finance LLC | 16.5% | 1,620,000 | SCHEDULE 13G, 2025-12-03 | 2025-11-25 |
| LifeSci Capital LLC | 7.9% | 2,200,000 | SCHEDULE 13G, 2026-01-13 | 2025-12-30 |
| SR One Capital Management, LLC | 4.6% | 344,176 | SCHEDULE 13D/A, 2025-10-15 | 2025-10-14 |
| Lazar David E. | 3.9% | 719,404 | SCHEDULE 13D/A, 2026-07-02 | 2026-05-20 |
| Baker Bros. Advisors LP | 0.01% | 2,312 | SCHEDULE 13G/A, 2026-05-15 | 2026-03-31 |
| Point72 Asset Management, L.P. | 0% | 257 | SCHEDULE 13G/A, 2025-11-14 | 2025-09-30 |
| Perceptive Advisors LLC | 0% | 0 | SCHEDULE 13G/A, 2025-11-14 | 2025-09-30 |
| Cormorant Asset Management, LP | 0% | 0 | SCHEDULE 13G/A, 2025-11-14 | 2025-09-30 |
Purpose of Transaction (Item 4)
SR One Capital Management, LLC
On October 7, 2025, Aggregator converted an aggregate of 4,110 shares of Series H Preferred Stock of the Issuer into 411,000 shares of the Issuer's Common Stock (the "Conversion"). Following the Conversion, on October 14, 2025, Aggregator sold 66,824 shares of the Issuer's Common Stock in a series of open market transactions. Schedule A attached hereto as Exhibit 2 describes all transactions in the Issuer's Common Stock that were effected by the Reporting Persons since the filing of Amendment No. 1. Depending on market conditions and other factors, Aggregator and the other Reporting Persons may dispose of additional shares of the Issuer. Except as set forth above, none of the Reporting Persons has any present plans which relate to or would result in: (a) The acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer; (b) An extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries; (c) A sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries; (d) Any change in the present board of directors or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board; (e) Any material change in the present capitalization or dividend policy of the Issuer; (f) Any other material change in the Issuer's business or corporate structure; (g) …The first part of Item 4 of the SCHEDULE 13D/A filed 2025-10-15; the filing has the rest
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-09-11 | Point72 Asset Management, L.P. | 6.7% | SCHEDULE 13G |
| 2025-09-11 | Perceptive Advisors LLC | 7.7% | SCHEDULE 13G |
| 2025-10-01 | SR One Capital Management, LLC | 5.5% | SCHEDULE 13D/A |
| 2025-10-02 | Baker Bros. Advisors LP | 9.99% | SCHEDULE 13D/A |
| 2025-10-03 | Baker Bros. Advisors LP | 9.99% | SCHEDULE 13G |
| 2025-10-15 | SR One Capital Management, LLC | 4.6% | SCHEDULE 13D/A |
| 2025-11-14 | Point72 Asset Management, L.P. | 0% | SCHEDULE 13G/A |
| 2025-11-14 | Cormorant Asset Management, LP | 0% | SCHEDULE 13G/A |
| 2025-11-14 | Perceptive Advisors LLC | 0% | SCHEDULE 13G/A |
| 2025-12-03 | Oxford Finance LLC | 16.5% | SCHEDULE 13G |
| 2026-01-13 | LifeSci Capital LLC | 7.9% | SCHEDULE 13G |
| 2026-02-06 | David E. Lazar | 5.18% | SCHEDULE 13D |
| 2026-02-17 | Baker Bros. Advisors LP | 9.99% | SCHEDULE 13G/A |
| 2026-05-15 | Baker Bros. Advisors LP | 0.01% | SCHEDULE 13G/A |
| 2026-07-02 | Lazar David E. | 3.9% | SCHEDULE 13D/A |
KALA BIO, Inc.: every filing and event
Tools for this story
Each opens in a new tab, filled in for KALA BIO, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.